Kliofem is a continuous combined hormone replacement therapy (HRT) used to treat symptoms of the menopause in women who have not had a period for at least 12 months. It is prescribed to relieve vasomotor symptoms such as hot flushes, night sweats, and mood changes. Kliofem is also effective in preventing postmenopausal bone loss (osteoporosis) in women at risk of fractures who cannot take other medications.
How It Works
Kliofem contains estradiol, an oestrogen, and norethisterone acetate, a progestogen. Estradiol replenishes declining oestrogen levels, which helps alleviate menopause symptoms. Norethisterone prevents the endometrial thickening caused by unopposed oestrogen in women with a uterus, reducing the risk of endometrial hyperplasia or cancer. This continuous combination allows for daily symptom control without monthly withdrawal bleeding.
Why Choose Kliofem
Kliofem is ideal for postmenopausal women seeking a once-daily HRT with consistent hormone delivery. It offers reliable symptom relief and supports bone density while minimising the risk of endometrial complications. The continuous, no-bleed regimen is preferred by many women who want a simplified HRT routine. Kliofem is well established in clinical practice and is considered a reliable option for long-term menopausal symptom management.
Important Note
This Medication is only for use by postmenopausal women and should not be used to prevent pregnancy. It must be prescribed following a full medical history and risk assessment. Kliofem is not suitable for women with a history of hormone-sensitive cancers, liver disease, or thromboembolic disorders. Regular reviews are recommended during long-term use. It is not suitable during pregnancy or breastfeeding.
